Covid-19 Impact on Global Antisense Therapy Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Antisense Therapy Revenue
• 1.4 Covid-19 Implications on Market by Type
  • 1.4.1 Global Antisense Therapy Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 RNA Antisense Therapy
  • 1.4.3 DNA Antisense Therapy
• 1.5 Market by Application
  • 1.5.1 Global Antisense Therapy Market Share by Application: 2020 VS 2026
  • 1.5.2 Cancer
  • 1.5.3 Cardiovascular
  • 1.5.4 HBV
  • 1.5.5 Other
• 1.6 Coronavirus Disease 2019 (Covid-19): Antisense Therapy Industry Impact
  • 1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
  • 1.6.2 Covid-19 Impact: Commodity Prices Indices
  • 1.6.3 Covid-19 Impact: Global Major Government Policy
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends

• 2.1 Covid-19 Implications on Global Antisense Therapy Market Perspective (2015-2026)
• 2.2 Covid-19 Implications on Global Antisense Therapy Growth Trends by Regions
  • 2.2.1 Antisense Therapy Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Antisense Therapy Historic Market Share by Regions (2015-2020)
  • 2.2.3 Antisense Therapy Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Antisense Therapy Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Antisense Therapy Players (Opinion Leaders)

3 Covid-19 Implications on Competition Landscape by Key Players

• 3.1 Global Top Antisense Therapy Players by Market Size
  • 3.1.1 Global Top Antisense Therapy Players by Revenue (2015-2020)
  • 3.1.2 Global Antisense Therapy Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Antisense Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Antisense Therapy Market Concentration Ratio
  • 3.2.1 Global Antisense Therapy Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Antisense Therapy Revenue in 2019
• 3.3 Antisense Therapy Key Players Head office and Area Served
• 3.4 Key Players Antisense Therapy Product Solution and Service
• 3.5 Date of Enter into Antisense Therapy Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Covid-19 Implications on Market Size by Type (2015-2026)

• 4.1 Global Antisense Therapy Historic Market Size by Type (2015-2020)
• 4.2 Global Antisense Therapy Forecasted Market Size by Type (2021-2026)

5 Covid-19 Implications on Market Size by Application (2015-2026)

• 5.1 Global Antisense Therapy Market Size by Application (2015-2020)
• 5.2 Global Antisense Therapy Forecasted Market Size by Application (2021-2026)

6 North America Impact of COVID-19

• 6.1 North America Antisense Therapy Market Size (2015-2020)
• 6.2 Antisense Therapy Key Players in North America (2019-2020)
• 6.3 North America Antisense Therapy Market Size by Type (2015-2020)
• 6.4 North America Antisense Therapy Market Size by Application (2015-2020)

7 Europe Impact of COVID-19

• 7.1 Europe Antisense Therapy Market Size (2015-2020)
• 7.2 Antisense Therapy Key Players in Europe (2019-2020)
• 7.3 Europe Antisense Therapy Market Size by Type (2015-2020)
• 7.4 Europe Antisense Therapy Market Size by Application (2015-2020)

8 China Impact of COVID-19

• 8.1 China Antisense Therapy Market Size (2015-2020)
• 8.2 Antisense Therapy Key Players in China (2019-2020)
• 8.3 China Antisense Therapy Market Size by Type (2015-2020)
• 8.4 China Antisense Therapy Market Size by Application (2015-2020)

9 Japan Impact of COVID-19

• 9.1 Japan Antisense Therapy Market Size (2015-2020)
• 9.2 Antisense Therapy Key Players in Japan (2019-2020)
• 9.3 Japan Antisense Therapy Market Size by Type (2015-2020)
• 9.4 Japan Antisense Therapy Market Size by Application (2015-2020)

10 Southeast Asia Impact of COVID-19

• 10.1 Southeast Asia Antisense Therapy Market Size (2015-2020)
• 10.2 Antisense Therapy Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Antisense Therapy Market Size by Type (2015-2020)
• 10.4 Southeast Asia Antisense Therapy Market Size by Application (2015-2020)

11 India Impact of COVID-19

• 11.1 India Antisense Therapy Market Size (2015-2020)
• 11.2 Antisense Therapy Key Players in India (2019-2020)
• 11.3 India Antisense Therapy Market Size by Type (2015-2020)
• 11.4 India Antisense Therapy Market Size by Application (2015-2020)

12 Central & South America Impact of COVID-19

• 12.1 Central & South America Antisense Therapy Market Size (2015-2020)
• 12.2 Antisense Therapy Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Antisense Therapy Market Size by Type (2015-2020)
• 12.4 Central & South America Antisense Therapy Market Size by Application (2015-2020)

13Key Players Profiles

• 13.1 Alnylam Pharmaceuticals
  • 13.1.1 Alnylam Pharmaceuticals Company Details
  • 13.1.2 Alnylam Pharmaceuticals Business Overview and Its Total Revenue
  • 13.1.3 Alnylam Pharmaceuticals Antisense Therapy Introduction
  • 13.1.4 Alnylam Pharmaceuticals Revenue in Antisense Therapy Business (2015-2020))
  • 13.1.5 Alnylam Pharmaceuticals Recent Development and Reaction to COVID-19
• 13.2 Ionis Pharmaceuticals, Inc.
  • 13.2.1 Ionis Pharmaceuticals, Inc. Company Details
  • 13.2.2 Ionis Pharmaceuticals, Inc. Business Overview and Its Total Revenue
  • 13.2.3 Ionis Pharmaceuticals, Inc. Antisense Therapy Introduction
  • 13.2.4 Ionis Pharmaceuticals, Inc. Revenue in Antisense Therapy Business (2015-2020)
  • 13.2.5 Ionis Pharmaceuticals, Inc. Recent Development and Reaction to COVID-19
• 13.3 Arbutus Biopharma (Tekmira)
  • 13.3.1 Arbutus Biopharma (Tekmira) Company Details
  • 13.3.2 Arbutus Biopharma (Tekmira) Business Overview and Its Total Revenue
  • 13.3.3 Arbutus Biopharma (Tekmira) Antisense Therapy Introduction
  • 13.3.4 Arbutus Biopharma (Tekmira) Revenue in Antisense Therapy Business (2015-2020)
  • 13.3.5 Arbutus Biopharma (Tekmira) Recent Development and Reaction to COVID-19
• 13.4 Isarna Therapeutics
  • 13.4.1 Isarna Therapeutics Company Details
  • 13.4.2 Isarna Therapeutics Business Overview and Its Total Revenue
  • 13.4.3 Isarna Therapeutics Antisense Therapy Introduction
  • 13.4.4 Isarna Therapeutics Revenue in Antisense Therapy Business (2015-2020)
  • 13.4.5 Isarna Therapeutics Recent Development and Reaction to COVID-19
• 13.5 Arrowhead
  • 13.5.1 Arrowhead Company Details
  • 13.5.2 Arrowhead Business Overview and Its Total Revenue
  • 13.5.3 Arrowhead Antisense Therapy Introduction
  • 13.5.4 Arrowhead Revenue in Antisense Therapy Business (2015-2020)
  • 13.5.5 Arrowhead Recent Development and Reaction to COVID-19
• 13.6 Dicerna Pharmaceuticals
  • 13.6.1 Dicerna Pharmaceuticals Company Details
  • 13.6.2 Dicerna Pharmaceuticals Business Overview and Its Total Revenue
  • 13.6.3 Dicerna Pharmaceuticals Antisense Therapy Introduction
  • 13.6.4 Dicerna Pharmaceuticals Revenue in Antisense Therapy Business (2015-2020)
  • 13.6.5 Dicerna Pharmaceuticals Recent Development and Reaction to COVID-19
• 13.7 Quark Pharmaceuticals
  • 13.7.1 Quark Pharmaceuticals Company Details
  • 13.7.2 Quark Pharmaceuticals Business Overview and Its Total Revenue
  • 13.7.3 Quark Pharmaceuticals Antisense Therapy Introduction
  • 13.7.4 Quark Pharmaceuticals Revenue in Antisense Therapy Business (2015-2020)
  • 13.7.5 Quark Pharmaceuticals Recent Development and Reaction to COVID-19
• 13.8 Benitec Biopharma
  • 13.8.1 Benitec Biopharma Company Details
  • 13.8.2 Benitec Biopharma Business Overview and Its Total Revenue
  • 13.8.3 Benitec Biopharma Antisense Therapy Introduction
  • 13.8.4 Benitec Biopharma Revenue in Antisense Therapy Business (2015-2020)
  • 13.8.5 Benitec Biopharma Recent Development and Reaction to COVID-19
• 13.9 Sylentis
  • 13.9.1 Sylentis Company Details
  • 13.9.2 Sylentis Business Overview and Its Total Revenue
  • 13.9.3 Sylentis Antisense Therapy Introduction
  • 13.9.4 Sylentis Revenue in Antisense Therapy Business (2015-2020)
  • 13.9.5 Sylentis Recent Development and Reaction to COVID-19
• 13.10 Gradalis
  • 13.10.1 Gradalis Company Details
  • 13.10.2 Gradalis Business Overview and Its Total Revenue
  • 13.10.3 Gradalis Antisense Therapy Introduction
  • 13.10.4 Gradalis Revenue in Antisense Therapy Business (2015-2020)
  • 13.10.5 Gradalis Recent Development and Reaction to COVID-19
• 13.11 Sarepta Therapeutics
  • 10.11.1 Sarepta Therapeutics Company Details
  • 10.11.2 Sarepta Therapeutics Business Overview and Its Total Revenue
  • 10.11.3 Sarepta Therapeutics Antisense Therapy Introduction
  • 10.11.4 Sarepta Therapeutics Revenue in Antisense Therapy Business (2015-2020)
  • 10.11.5 Sarepta Therapeutics Recent Development and Reaction to COVID-19
• 13.12 Biogen
  • 10.12.1 Biogen Company Details
  • 10.12.2 Biogen Business Overview and Its Total Revenue
  • 10.12.3 Biogen Antisense Therapy Introduction
  • 10.12.4 Biogen Revenue in Antisense Therapy Business (2015-2020)
  • 10.12.5 Biogen Recent Development and Reaction to COVID-19

14Analyst's Viewpoints/Conclusions

15Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer